Litigation Details for SAGENT PHARMACEUTICALS, INC. v. GLENMARK GENERICS INC (D.C. 2015)
✉ Email this page to a colleague
SAGENT PHARMACEUTICALS, INC. v. GLENMARK GENERICS INC (D.C. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-07-22 |
Court | District Court, District of Columbia | Date Terminated | |
Cause | Motion to Compel | Assigned To | John D. Bates |
Jury Demand | None | Referred To | |
Patents | 6,774,122; 7,456,160; 8,329,680 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SAGENT PHARMACEUTICALS, INC. v. GLENMARK GENERICS INC
Details for SAGENT PHARMACEUTICALS, INC. v. GLENMARK GENERICS INC (D.C. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-07-22 | 1 | U.S. Patent Nos. 6,774.122; 7,456,160; 8,329,680; and 8.466,139 (collectively. "patents-in-suit…filing date of U.S. Patent No. 6,774,122 (which is the earliest filed of the patents-in-suit). (Peterson… things, that the patents-in-suit are invalid in view of certain prior art patents and publications directed… 103, a patent is invalid as anticipated and/or obvious if: "the invention was patented or described…No. EP1250138, which is a related patent application to the patents-in-suit, providing statements relating | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |